| | On the second European Panel on the Appropriateness of Crohn's disease Therapy (EPACT-II)Received 4 September 2009; accepted 4 September 2009. No abstract is available. To read the body of this article, please view the Full Text online. |
Cerner LifeSciences, Beverly Hills, CA 90212, USA PII: S1873-9946(09)00098-1 doi:10.1016/j.crohns.2009.09.002 © 2009 European Crohn's and Colitis Organisation. Published by Elsevier Inc. All rights reserved. | |
|
|
